These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

701 related articles for article (PubMed ID: 9895414)

  • 21. Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres.
    Fu K; Pack DW; Klibanov AM; Langer R
    Pharm Res; 2000 Jan; 17(1):100-6. PubMed ID: 10714616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-loaded biodegradable PLGA microcapsules: initial burst release controlled by hydrophilic additives.
    Yamaguchi Y; Takenaga M; Kitagawa A; Ogawa Y; Mizushima Y; Igarashi R
    J Control Release; 2002 Jun; 81(3):235-49. PubMed ID: 12044564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery.
    Woo BH; Jiang G; Jo YW; DeLuca PP
    Pharm Res; 2001 Nov; 18(11):1600-6. PubMed ID: 11758769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and characterization of poly(D,L-lactic-co-glycolic Acid) microspheres containing flurbiprofen sodium.
    Samati Y; Yüksel N; Tarimci N
    Drug Deliv; 2006; 13(2):105-11. PubMed ID: 16423798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid oligomers: Part II. Biodegradation and drug delivery application.
    Wang N; Wu XS
    J Biomater Sci Polym Ed; 1997; 9(1):75-87. PubMed ID: 9505204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sustained release of heparin from polymeric particles for inhibition of human vascular smooth muscle cell proliferation.
    Yang Z; Birkenhauer P; Julmy F; Chickering D; Ranieri JP; Merkle HP; Lüscher TF; Gander B
    J Control Release; 1999 Aug; 60(2-3):269-77. PubMed ID: 10425332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo release properties of brilliant blue and tumour necrosis factor-alpha (TNF-alpha) from poly(D,L-lactic-co-glycolic acid) multiphase microspheres.
    Iwata M; Nakamura Y; McGinity JW
    J Microencapsul; 1999; 16(6):777-92. PubMed ID: 10575629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of different grades of PLGA on characteristics of microspheres encapsulated with cyclosporine A.
    Malaekeh-Nikouei B; Sajadi Tabassi SA; Jaafari MR
    Curr Drug Deliv; 2006 Oct; 3(4):343-9. PubMed ID: 17076635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and characterization of biodegradable urea-loaded microparticles as an approach for transdermal delivery.
    Haddadi A; Farboud ES; Erfan M; Aboofazeli R
    J Microencapsul; 2006 Sep; 23(6):698-712. PubMed ID: 17118885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Porcine insulin biodegradable polyester microspheres: stability and in vitro release characteristics.
    Shao PG; Bailey LC
    Pharm Dev Technol; 2000; 5(1):1-9. PubMed ID: 10669912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tetracycline-HCl-loaded poly(DL-lactide-co-glycolide) microspheres prepared by a spray drying technique: influence of gamma-irradiation on radical formation and polymer degradation.
    Bittner B; Mäder K; Kroll C; Borchert HH; Kissel T
    J Control Release; 1999 May; 59(1):23-32. PubMed ID: 10210719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and evaluation of poly (D, L-lactic acid) (PLA) or D, L-lactide/glycolide copolymer (PLGA) microspheres with estradiol.
    Xinteng Z; Weisan P; Ruhua Z; Feng Z
    Pharmazie; 2002 Oct; 57(10):695-7. PubMed ID: 12426951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poly(D,L-lactic-co-glycolic acid) microspheres for sustained delivery and stabilization of camptothecin.
    Ertl B; Platzer P; Wirth M; Gabor F
    J Control Release; 1999 Sep; 61(3):305-17. PubMed ID: 10477803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stabilization of Human Immunoglobulin G Encapsulated within Biodegradable Poly (Cyclohexane-1, 4-diyl Acetone Dimethylene Ketal) (PCADK)/ Poly (Lactic-co-Glycolic Acid) (PLGA) Blend Microspheres.
    Wang C; Yu C; Liu J; Sun F; Teng L; Li Y
    Protein Pept Lett; 2015; 22(11):963-71. PubMed ID: 26268563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of formulation parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA.
    Capan Y; Woo BH; Gebrekidan S; Ahmed S; DeLuca PP
    J Control Release; 1999 Aug; 60(2-3):279-86. PubMed ID: 10425333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utilization of an amorphous form of a water-soluble GPIIb/IIIa antagonist for controlled release from biodegradable microspheres.
    Takada S; Kurokawa T; Miyazaki K; Iwasa S; Ogawa Y
    Pharm Res; 1997 Sep; 14(9):1146-50. PubMed ID: 9327440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controlled delivery of a hydrophilic drug from a biodegradable microsphere system by supercritical anti-solvent precipitation technique.
    Lee S; Kim MS; Kim JS; Park HJ; Woo JS; Lee BC; Hwang SJ
    J Microencapsul; 2006 Nov; 23(7):741-9. PubMed ID: 17123918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulated release of IdUrd from poly (D,L-lactide-co-glycolide) microspheres by addition of poly (D,L-lactide) oligomers.
    Geze A; Venier-Julienne MC; Saulnier P; Varlet P; Daumas-Duport C; Devauchelle P; Benoit JP
    J Control Release; 1999 Apr; 58(3):311-22. PubMed ID: 10099156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(D,L-lactide-co-glycolide) microsphere.
    Su Z; Sun F; Shi Y; Jiang C; Meng Q; Teng L; Li Y
    Chem Pharm Bull (Tokyo); 2009 Nov; 57(11):1251-6. PubMed ID: 19881277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Manufacture of porous biodegradable polymer conduits by an extrusion process for guided tissue regeneration.
    Widmer MS; Gupta PK; Lu L; Meszlenyi RK; Evans GR; Brandt K; Savel T; Gurlek A; Patrick CW; Mikos AG
    Biomaterials; 1998 Nov; 19(21):1945-55. PubMed ID: 9863528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.